Cargando…

Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures

The outbreak of a novel febrile respiratory disease called COVID-19, caused by a newfound coronavirus SARS-CoV-2, has brought a worldwide attention. Prioritizing approved drugs is critical for quick clinical trials against COVID-19. In this study, we first manually curated three Virus-Drug Associati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Lihong, Shen, Ling, Xu, Junlin, Tian, Xiongfei, Liu, Fuxing, Wang, Juanjuan, Tian, Geng, Yang, Jialiang, Zhou, Liqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973547/ https://www.ncbi.nlm.nih.gov/pubmed/33737523 http://dx.doi.org/10.1038/s41598-021-83737-5

Ejemplares similares

Identifying Effective Antiviral Drugs Against SARS-CoV-2 by Drug Repositioning Through Virus-Drug Association Prediction
por: Peng, Lihong, et al.
Publicado: (2020)

Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method
por: Zhou, Liqian, et al.
Publicado: (2020)

VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares()
por: Shen, Ling, et al.
Publicado: (2022)

Revealing Drug-Target Interactions with Computational Models and Algorithms
por: Zhou, Liqian, et al.
Publicado: (2019)

Discovery of Potential Therapeutic Drugs for COVID-19 Through Logistic Matrix Factorization With Kernel Diffusion
por: Tian, Xiongfei, et al.
Publicado: (2022)

Identifying Small Molecule-miRNA Associations Based on Credible Negative Sample Selection and Random Walk
por: Liu, Fuxing, et al.
Publicado: (2020)

Probing lncRNA–Protein Interactions: Data Repositories, Models, and Algorithms
por: Peng, Lihong, et al.
Publicado: (2020)

Screening Potential Drugs for COVID-19 Based on Bound Nuclear Norm Regularization
por: Wang, Juanjuan, et al.
Publicado: (2021)

Computational drug repositioning using similarity constrained weight regularization matrix factorization: A case of COVID‐19
por: Xu, Junlin, et al.
Publicado: (2022)

A novel lncRNA–protein interaction prediction method based on deep forest with cascade forest structure
por: Tian, Xiongfei, et al.
Publicado: (2021)

LPI-deepGBDT: a multiple-layer deep framework based on gradient boosting decision trees for lncRNA–protein interaction identification
por: Zhou, Liqian, et al.
Publicado: (2021)

Antiviral Drugs for Viral Pneumonia
por: Bansal, Tapesh
Publicado: (2023)

A deep learning ensemble approach to prioritize antiviral drugs against novel coronavirus SARS-CoV-2 for COVID-19 drug repurposing
por: K., Deepthi, et al.
Publicado: (2021)

An Ensemble Matrix Completion Model for Predicting Potential Drugs Against SARS-CoV-2
por: Li, Wen, et al.
Publicado: (2021)

Initiation of Antiviral Treatment in SARS‐CoV2: Modeling Viral Dynamics and Drug Properties
por: Rosenbloom, Daniel Scholes, et al.
Publicado: (2020)

LPI-HyADBS: a hybrid framework for lncRNA-protein interaction prediction integrating feature selection and classification
por: Zhou, Liqian, et al.
Publicado: (2021)

Inferring Latent Disease-lncRNA Associations by Faster Matrix Completion on a Heterogeneous Network
por: Li, Wen, et al.
Publicado: (2019)

Diagnosis of viral disease and the advent of antiviral drugs
por: Herrmann, Ernest C., et al.
Publicado: (1979)

Drug repositioning based on weighted local information augmented graph neural network
por: Meng, Yajie, et al.
Publicado: (2023)

Sars-Cov-2 and risk of antiviral drug resistance
por: Vitiello, Antonio
Publicado: (2021)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Model‐informed drug repurposing: Viral kinetic modelling to prioritize rational drug combinations for COVID‐19
por: Dodds, Michael G., et al.
Publicado: (2020)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning
por: Ackerman, Emily E., et al.
Publicado: (2020)

Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation
por: Serra, Angela, et al.
Publicado: (2021)

Dewormer drug fenbendazole has antiviral effects on BoHV-1 productive infection in cell cultures
por: Chang, Long, et al.
Publicado: (2020)

Metabolite profiling studies in Saccharomyces cerevisiae: an assisting tool to prioritize host targets for antiviral drug screening
por: Schneider, Konstantin, et al.
Publicado: (2009)

Inhalation of vaccines and antiviral drugs to fight respiratory virus infections: reasons to prioritize the pulmonary route of administration
por: Heida, Rick, et al.
Publicado: (2023)

An Improved Anticancer Drug-Response Prediction Based on an Ensemble Method Integrating Matrix Completion and Ridge Regression
por: Liu, Chuanying, et al.
Publicado: (2020)

Antiviral Drugs, Mode of Action and Chemotherapy of Viral Infections of Man
por: Prusoff, William H.
Publicado: (1977)

The viral RNA capping machinery as a target for antiviral drugs
por: Ferron, François, et al.
Publicado: (2012)

A Novel Approach of Antiviral Drugs Targeting Viral Genomes
por: Hoang, Phuong Thi, et al.
Publicado: (2022)

Inferring SARS-CoV-2 functional genomics from viral transcriptome with identification of potential antiviral drugs and therapeutic targets
por: Pan, Xu, et al.
Publicado: (2021)

Biased random walk model for the prioritization of drug resistance associated proteins
por: Guo, Hao, et al.
Publicado: (2015)

Pre-Clinical Drug Prioritization via Prognosis-Guided Genetic Interaction Networks
por: Xiong, Jianghui, et al.
Publicado: (2010)

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
por: Jeon, Sangeun, et al.
Publicado: (2020)

Identification of the natural product berberine as an antiviral drug
por: Shao, Jiping, et al.
Publicado: (2020)

Systems Chemical Genetics-Based Drug Discovery: Prioritizing Agents Targeting Multiple/Reliable Disease-Associated Genes as Drug Candidates
por: Quan, Yuan, et al.
Publicado: (2019)

The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs
por: Li, Yanbai, et al.
Publicado: (2023)

Antiviral Drugs
por: Vardanyan, Ruben, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r1eobafoogse1oas5lfkfut9sm